Cancer Incidence for Tottenville, Great Kills & Annadale, Richmond (Staten Island) County, 2016-2020
Source: New York State Cancer Registry
| Site of Cancer | Males and Females | Males | Females | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 1,133.2 | 548.1 | 533.5-563.1 | 552.4 | 577.5 | 555.4-600.4 | 580.8 | 531.2 | 511.4-551.7 |
| Oral cavity and pharynx | 24.0 | 11.7 | 9.6-14.1 | 16.8 | 17.2 | 13.6-21.5 | 7.2 | 6.9 | 4.7-9.7 |
| Esophagus | 9.2 | 4.2 | 3.1-5.7 | 8.2 | 8.3 | 5.9-11.5 | 1.0 | 0.9 | 0.3-2.3 |
| Stomach | 17.4 | 8.6 | 6.8-10.7 | 10.0 | 11.1 | 8.1-14.8 | 7.4 | 6.7 | 4.6-9.4 |
| Colorectal | 87.4 | 43.1 | 39.0-47.4 | 49.4 | 52.9 | 46.3-60.2 | 38.0 | 34.6 | 29.8-40.1 |
| Colon excluding rectum | 64.4 | 31.7 | 28.2-35.4 | 35.8 | 38.5 | 32.9-44.9 | 28.6 | 25.9 | 21.7-30.7 |
| Rectum & rectosigmoid | 23.0 | 11.4 | 9.4-13.8 | 13.6 | 14.4 | 11.0-18.4 | 9.4 | 8.7 | 6.4-11.8 |
| Liver / intrahepatic bile duct | 20.2 | 9.4 | 7.6-11.5 | 14.6 | 14.4 | 11.2-18.4 | 5.6 | 5.1 | 3.4-7.5 |
| Pancreas | 30.6 | 14.1 | 11.9-16.6 | 14.6 | 14.4 | 11.2-18.4 | 16.0 | 13.6 | 10.8-17.1 |
| Larynx | 7.0 | 3.4 | 2.3-4.8 | 5.4 | 5.9 | 3.8-8.7 | 1.6 | 1.4 | 0.6-2.9 |
| Lung and bronchus | 145.4 | 68.6 | 63.6-73.9 | 67.4 | 74.1 | 66.1-82.8 | 78.0 | 65.7 | 59.2-72.7 |
| Melanoma of the skin | 36.4 | 17.8 | 15.2-20.7 | 20.4 | 21.3 | 17.2-26.1 | 16.0 | 15.1 | 11.9-19.0 |
| Female breast | 163.8 | 149.7 | 139.2-160.8 | ||||||
| Cervix uteri | 7.8 | 8.4 | 5.9-11.7 | ||||||
| Corpus uterus and NOS | 42.0 | 35.6 | 30.8-41.0 | ||||||
| Ovary | 16.8 | 15.2 | 12.0-19.0 | ||||||
| Prostate | 128.2 | 122.3 | 112.7-132.6 | ||||||
| Testis | 4.6 | 6.5 | 4.1-9.7 | ||||||
| Urinary bladder (incl. in situ) | 62.8 | 30.0 | 26.7-33.7 | 45.8 | 49.6 | 43.2-56.8 | 17.0 | 14.4 | 11.5-18.0 |
| Kidney and renal pelvis | 52.2 | 24.5 | 21.5-27.8 | 35.0 | 35.5 | 30.2-41.4 | 17.2 | 15.1 | 12.0-18.9 |
| Brain and other central nervous system | 14.6 | 7.9 | 6.1-10.0 | 8.6 | 9.9 | 7.1-13.5 | 6.0 | 5.9 | 3.9-8.5 |
| Thyroid | 67.0 | 37.0 | 33.0-41.3 | 19.8 | 22.5 | 18.2-27.7 | 47.2 | 50.9 | 44.3-58.2 |
| Hodgkin lymphoma | 5.8 | 3.7 | 2.5-5.4 | 3.4 | 4.4 | 2.5-7.1 | 2.4 | 3.1 | 1.6-5.4 |
| Non-Hodgkin lymphomas | 51.8 | 24.7 | 21.7-28.0 | 28.2 | 29.6 | 24.8-35.2 | 23.6 | 20.7 | 17.0-25.0 |
| Myeloma | 19.2 | 9.0 | 7.3-11.1 | 10.6 | 11.3 | 8.4-15.0 | 8.6 | 7.3 | 5.2-10.0 |
| Leukemias | 34.2 | 17.1 | 14.5-19.9 | 19.8 | 20.6 | 16.6-25.3 | 14.4 | 14.2 | 11.0-18.1 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYC neighborhoods were defined in terms of Public Use Microdata Areas (PUMAs). PUMAs approximate NYC Community Districts (CDs).
- For more information about PUMAs, please refer to http://www1.nyc.gov/site/planning/data-maps/nyc-population/geographic-reference.page.
